JCR Pharmaceuticals: Corporate Governance Report 2024/09/12
JCR Pharmaceuticals: Corporate Governance Report, July 12, 2024.
JCR Pharmaceuticals: Internal Control Report - 49th Term (2023/04/01 - 2024/03/31)
JCR Pharmaceuticals: Other electronic measures for providing materials for the 2024 regular shareholders' meeting.
JCR Pharmaceuticals: Other matters that will be subject to electronic provision measures at the 49th regular meeting of shareholders.
JCR Pharmaceuticals: Notice of the convocation of the 49th regular shareholder meeting.
JCR Pharmaceuticals: Notice of the scheduled 2024 Shareholders' General Meeting and General Meeting materials.
JCR Pharmaceuticals: Report on corporate governance 2023/11/16
JCR Pharmaceuticals: Report on Corporate Governance 2023/07/06
JCR Pharmaceuticals: Internal Control Report - 48th Period (2022/04/01 - 2023/03/31)
JCR Pharmaceuticals: (Corrections) Partial revisions to the “2023 Annual General Meeting of Shareholders Convocation Notice and Shareholders' Meeting Materials”
JCR Pharmaceuticals: Other Matters Subject to Measures for Electronic Provision When Convening the 48th Ordinary General Meeting of Shareholders
JCR Pharmaceuticals: Notice of Convocation of The 48th Ordinary General Meeting of Shareholders
JCR Pharmaceuticals: 2023 Annual General Meeting of Shareholders Materials and Other Measures for Electronic Provision
JCR Pharmaceuticals: 2023 Annual General Meeting of Shareholders Convocation Notice and Shareholders' Meeting Materials
JCR Pharmaceuticals Co Ltd: Report on corporate governance 2022-07-12
JCR Pharmaceuticals Co Ltd: Internal Control report-No. 47 (order and 1 April 3-order and 31 March 4)
JCR Pharmaceuticals Co Ltd: Items Disclosed on the Internet Concerning the Notice of Convocation of the 47th Ordinary General Meeting of Shareholders 2022
JCR Pharmaceuticals Co Ltd: Some amendments to the "Internet Disclosure at the time of the notice of the 2022 Annual General meeting"
JCR Pharmaceuticals Co Ltd: (correction) partial correction of the notice of convening of the Annual General meeting of shareholders in 2022
No Data
No Data